IPRIPR2023-00608Institution Denied
Novartis Gene Therapies, Inc. et al.v.Genzyme Corporation et al.
IPR challenge of US 9051542.
Type
IPR
Filed
Feb 22, 2023
Instituted
Aug 30, 2023
Decided
Aug 30, 2023
Patent
Application
12661553
Inventor
John Fraser Wright et al
Granted
Jun 9, 2015
01
Timeline
3 milestones
2023-02-22Petition filed
2023-08-30Institution
2023-08-30Terminated
02
Parties & counsel
Petitioner
Novartis Gene Therapies, Inc. et al.
Counsel
Livingstone, Johnet al
Patent Owner
Genzyme Corporation et al.
Counsel
Antons, Amandaet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →